Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 5 min ago
PreprintAll rights reservedbioRxiv

Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets

  • N. Bagherlou
  • S. Aliyari1
  • Z. Salehi
  • M. Pirouzkhah
  • C.-A. Weis
  1. 1Section Computational Pathology Heidelberg, Institute of Pathology Heidelberg, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany
Read full textPDFDOICite

Related

  1. Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming
    Yuhong Gao, Xiulin Dong, Sijia Hua +3
    EBioMedicinePeer-reviewedCC BY-NCFull textOncologyEurope PMCCrossref
  2. Why Circulating Interleukin‐6 Is Not Yet a Standalone Clinically Actionable Biomarker in HFrEF: A Context‐of‐Use Review
    Yongxin Ye, Martina Colombo, Jennifer Meessen +9
    European journal of clinical investigationPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. 974 Integrated multimodal profiling reveals conserved type II interferon signalling, ectopic lymphoid structure formation, and actionable inflammatory endotypes in cutaneous immune-related adverse events
    James Larkin, Samra Turajlic, Teena Thakur +10
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. Clinically Actionable Prevention and Management of Major Complications During Durable Left Ventricular Assist Device Support: A Contemporary Narrative Review
    Wei Yong Sheng, Tian Sheng Tang, You Shi Wu +3
    Cardiology researchPeer-reviewedCC BYFull textCardiovascular medicineEurope PMCPMC
  5. Predicting clinically actionable metagenomic next-generation sequencing in sepsis through dynamic inflammatory trajectories
    Xiaocheng Ding, Peng Bao, Xiaopeng Huang +5
    Frontiers in MicrobiologyPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@misc{bagherlou2026pancancer,
  title = {{Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets}},
  author = {N. Bagherlou and S. Aliyari and Z. Salehi and M. Pirouzkhah and C.-A. Weis},
  howpublished = {bioRxiv},
  year = {2026},
  month = aug,
  doi = {10.64898/2026.08.30.748071},
  url = {https://www.biorxiv.org/content/10.64898/2026.08.30.748071v1},
}
RIS
TY  - UNPB
TI  - Pan-cancer analysis identifies nine conserved miRNA regulators of tumor cytolytic activity and clinically actionable immune targets
AU  - N. Bagherlou
AU  - S. Aliyari
AU  - Z. Salehi
AU  - M. Pirouzkhah
AU  - C.-A. Weis
PY  - 2026
DA  - 2026/08/30
PB  - bioRxiv
DO  - 10.64898/2026.08.30.748071
UR  - https://www.biorxiv.org/content/10.64898/2026.08.30.748071v1
ER  -